FDA.reportPublic FDA data

aprepitant 125 MG Powder for Oral Suspension

RxCUI
1729308
RxNorm name
aprepitant 125 MG Powder for Oral Suspension
Display name
aprepitant 125 MG Powder for Oral Suspension
Full name
aprepitant 125 MG Powder for Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
696f9e80-9cae-403b-de9e-078343ce4713aprepitant 125 MG Powder for Oral Suspension [PSN] · aprepitant 125 MG Powder for Oral Suspension [SCD]242These highlights do not include all the information needed to use EMEND CAPSULES and EMEND FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EMEND CAPSULES and EMEND FOR ORAL SUSPENSION. EMEND (aprepitant) capsules, for oral use EMEND (aprepitant) for oral suspension Initial U.S. Approval: 200320240705